Related Experiment Video
Updated: Jan 11, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Cardiac Channelopathies in the Pediatric Patient: Short QT Syndrome
Reina Bianca Tan1, Maully J Shah2
1Division of Cardiology, Department of Pediatrics, NYU Langone Health and Hassenfeld Children's Hospital, 403 East 34th Street, Level 3, New York, NY 10016, USA.
Insights
Short QT Syndrome is a rare genetic disorder causing dangerous heart arrhythmias. Management focuses on preventing sudden cardiac arrest through ICDs and antiarrhythmic drugs like quinidine.
Area of Science:
- Cardiology
- Genetics
- Electrophysiology
Background:
- Short QT Syndrome (SQTS) is a rare inherited arrhythmia disorder.
- Characterized by accelerated cardiac repolarization and a short QT interval on ECG.
- Associated with a high risk of life-threatening atrial and ventricular arrhythmias, including sudden cardiac arrest.
Abstract:
Short QT Syndrome is a rare inherited arrhythmia disorder marked by accelerated repolarization and a short QT interval. It carries a high risk of atrial and ventricular arrhythmias, including sudden cardiac arrest. Genetic mutations are identified in 20% to 30% of cases, most commonly in potassium channel genes (KCNH2, KCNQ1, KCNJ2). Management includes ICD implantation for secondary prevention and antiarrhythmic therapy, with quinidine being the most established agent for QT prolongation and arrhythmia suppression.
Related Concept Videos
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Mechanism of Cardiac Arrhythmias
Cardiomyopathy III: Hypertrophic Cardiomyopathy

